Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results